
    
      This is a phase 2 trial with 7 strata :

        -  Leiomyosarcoma (strata 1) : 33 patients

        -  Undifferentiated sarcoma (strata 2): 33 patients

        -  Sarcomas others (strata 3) : 33 patients

        -  Osteosarcoma (strata 4) : 33 patients

        -  GIST (strata 5): 31 patients

        -  Advanced soft-tissue sarcoma with immune signature (strata 6): 32 patients

        -  Metastatic soft-tissue sarcoma (strata 7): 32 patients
    
  